Difference of Intrahost Dynamics of the Second Human Pegivirus and Hepatitis C Virus in HPgV-2/HCV- Coinfected Patients

被引:5
|
作者
Liang, Yuanhao [1 ]
Hu, Fengyu [2 ]
Fan, Hang [3 ]
Li, Linghua [2 ]
Wan, Zhengwei [1 ]
Wang, Haiying [1 ]
Shui, Jingwei [1 ]
Zhou, Yuanping [4 ]
Tong, Yigang [5 ]
Cai, Weiping [2 ]
Tang, Shixing [1 ,6 ]
机构
[1] Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Peoples R China
[2] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Peoples R China
[3] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Peoples R China
[5] Beijing Univ Chem Technol, Sch Life Sci & Technol, Beijing, Peoples R China
[6] Univ Chinese Acad Sci, Wenzhou Inst, Wenzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
HPgV-2; HCV; coinfection; intrahost variants; cytokine; INJECT DRUGS; INFECTION; HCV; TRANSMISSION;
D O I
10.3389/fcimb.2021.728415
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The second human pegivirus (HPgV-2) and hepatitis C virus (HCV) belong to the Flaviviridae family and share some common genome features. However, the two viruses exhibit significantly different genetic diversity. The comparison of intrahost dynamics of HPgV-2 and HCV that mainly reflect virus-host interactions is needed to elucidate their intrahost difference of genetic diversity and the possible mechanisms. Methods: Intrahost single nucleotide variations (iSNVs) were identified by means of next generation sequencing from both cross-sectional and longitudinal samples from HPgV-2- and HCV-coinfected patients. The levels of human cytokines were quantified in the patient before and after HCV elimination by the treatment of direct-acting antivirals (DAA). Results: Unlike HCV, the viral sequences of HPgV-2 are highly conserved among HPgV2-infected patients. However, iSNV analysis confirmed the intrahost variation or quasispecies of HPgV-2. Almost all iSNVs of HPgV-2 did not accumulate or transmit within host over time, which may explain the highly conserved HPgV-2 consensus sequence. Intrahost variation of HPgV-2 mainly causes nucleotide transition in particular at the 3rd codon position and synonymous substitutions, indicating purifying or negative selection posed by host immune system. Cytokine data further indicate that HPgV-2 infection alone may not efficiently stimulate innate immune responses since proinflammatory cytokine expression dramatically decreased with elimination of HCV. Conclusion: This study provided new insights into the intrahost genomic variations and evolutionary dynamics of HPgV-2 as well as the impact of host immune selection and virus polymerase on virus evolution. The different genetic diversity of HPgV-2 and HCV makes HPgV-2 a potential new model to investigate RNA virus diversity and the mechanism of viral polymerase in modulating virus replication.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication
    Wan, Zhengwei
    Liu, Junwei
    Hu, Fengyu
    Shui, Jingwei
    Li, Linghua
    Wang, Haiying
    Tang, Xiaoping
    Hu, Chengguang
    Liang, Yuanhao
    Zhou, Yuanping
    Cai, Weiping
    Tang, Shixing
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 485 - 495
  • [2] A Novel Human Pegivirus, HPgV-2 (HHpgV-1), Is Tightly Associated With Hepatitis C Virus (HCV) Infection and HCV/Human Immunodeficiency Virus Type 1 Coinfection
    Wang, Haiying
    Wan, Zhengwei
    Xu, Ru
    Guan, Yujuan
    Zhu, Naling
    Li, Jianping
    Xie, Zhiwei
    Lu, Aiqi
    Zhang, Fuchun
    Fu, Yongshui
    Tang, Shixing
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (01) : 29 - 35
  • [3] Infection of human pegivirus 2 (HPgV-2) is associated with hepatitis C virus but not hepatitis B virus infection in people who inject drugs
    Shui, Jingwei
    Liu, Wenpei
    Liang, Yuanhao
    Zhang, Jian
    Wan, Zhengwei
    Wang, Haiying
    Qu, Xiaowang
    Tang, Shixing
    JOURNAL OF GENERAL VIROLOGY, 2019, 100 (06): : 968 - 974
  • [4] Identification of near full-length human pegivirus type 2 (HPgV-2) genomes in blood donor samples co-infected with hepatitis C virus (HCV)
    Ragupathy, Viswanath
    Kelley, Kylan
    Hewlett, Indira
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2025, 14 (03)
  • [5] Comparison of methodologies for quantification of hepatitis C virus (HCV) RNA in patients coinfected with HCV and human immunodeficiency virus
    Sherman, KE
    Rouster, SD
    Horn, PS
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (04) : 482 - 487
  • [6] Low levels of hepatitis C virus (HCV) neutralizing antibodies in patients coinfected with HCV and human immunodeficiency virus
    Castelain, Sandrine
    Schnuriger, Aurelie
    Francois, Catherine
    Nguyen-Khac, Eric
    Fournier, Carole
    Schmit, Jean-Luc
    Capron, Dominique
    Dubuisson, Jean
    Wychowski, Czeslaw
    Thibault, Vincent
    Duverlie, Gilles
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (03): : 332 - 335
  • [7] Interferon therapy in patients coinfected with hepatitis C (HCV) and human immunodeficiency virus (HIV).
    Venkataramani, A
    Rond, R
    Beaumont, C
    Lyche, K
    HEPATOLOGY, 1997, 26 (04) : 738 - 738
  • [8] Quantitation of hepatitis C virus RNA in saliva and serum of patients coinfected with HCV and human immunodeficiency virus
    Rey, D
    Fritsch, S
    Schmitt, C
    Meyer, P
    Lang, JM
    Stoll-Keller, F
    JOURNAL OF MEDICAL VIROLOGY, 2001, 63 (02) : 117 - 119
  • [9] Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients
    Carrero, Ana
    Berenguer, Juan
    Hontanon, Victor
    Guardiola, Josep M.
    Navarro, Jordi
    von Wichmann, Miguel A.
    Tellez, Maria J.
    Quereda, Carmen
    Santos, Ignacio
    Sanz, Jose
    Galindo, Maria J.
    Hernandez-Quero, Jose
    Jimenez-Sousa, Maria A.
    Perez-Latorre, Leire
    Bellon, Jose M.
    Resino, Salvador
    Esteban, Herminia
    Martinez, Esteban
    Gonzalez-Garcia, Juan
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E2026 - E2033
  • [10] Hepatitis C virus (HCV) genotypes and disease progression in HIV/HCV-coinfected patients
    Núñez, M
    Soriano, V
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (01): : 1 - 3